Discover the insights you need to make better decisions today, to shape the future with confidence.
See more
Services
EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
Spotlight
Industries
Discover how EY insights and services are helping to reframe the future of your industry.
See more
Case studies
Energy resources
How AI drove data optimization for oil and gas capital projects
06 Aug 2025EY Global
Strategy and Transactions
Rivada is reimagining wireless internet as a commodity
11 Jul 2025EY Global
About us
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
Recent Searches
Trending
What if disruption isn't the challenge, but the chance?
Transform your business and thrive in the NAVI world of nonlinear, accelerated, volatile and interconnected change. Discover how.
26 Jun 2025 EY wavespace™
Geostrategic Analysis: May 2026
Read the May 2026 Geostrategic Analysis for our take on geopolitical developments and the impact of these political risks on international business.
12 May 2026 Geostrategy
How can reimagining today's workforce help banks shape their future?
By focusing on four bold imperatives, banks can differentiate in the competition for top talent and drive higher returns on people investments.
09 Sep 2025The need for innovation to achieve future growth targets will drive the biopharma M&A activities, mainly strategic partnerships and bolt-on acquisitions.
EY-Parthenon Global Life Sciences Deals Leader
Committed to helping life sciences companies create focused business models that outperform. Loves road trips and the outdoors.
Subin is a partner at Ernst & Young LLP and the EY-Parthenon Global Life Sciences Deals Leader. He has more than a decade of transaction experience, helping life sciences companies with transformational transactions.
Subin has extensive global experience serving as a buy- and sell-side transaction advisor for Fortune 500 companies, including in corporate and private equity. His experience includes working with companies in the pharmaceutical, medical device and biotechnology subsectors.
Subin focuses on acquisitions, carve-outs, spin-offs and initial public offerings and works with companies at all stages of maturity, from startups to public companies. He frequently speaks at life sciences events about sector trends and acquisitions and divestitures topics.
He received his Master of Commerce from Macquarie University in Sydney, Australia. He is a chartered accountant from the Institute of Chartered Accountants of Australia and New Zealand.
"I am helping to build a better working world by advising global life sciences companies of all sizes on how to remain agile at a time of dynamic change. By asking better questions, I work closely alongside these companies to help them create new high-growth investment and portfolio optimization opportunities."